Olaplex (NASDAQ:OLPX) Raised to Hold at Wall Street Zen

Olaplex (NASDAQ:OLPX) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday.

Other equities analysts have also recently issued reports about the company. Zacks Research upgraded Olaplex from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 19th. Barclays set a $1.75 price target on shares of Olaplex in a research note on Friday, January 16th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Olaplex in a report on Wednesday. Weiss Ratings reiterated a “sell (d)” rating on shares of Olaplex in a research note on Thursday, January 22nd. Finally, Telsey Advisory Group reissued a “market perform” rating and set a $2.00 price objective on shares of Olaplex in a report on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $1.96.

Olaplex Stock Down 8.2%

Shares of NASDAQ OLPX opened at $1.35 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 4.00 and a current ratio of 4.58. Olaplex has a 1 year low of $0.99 and a 1 year high of $1.84. The stock’s 50-day simple moving average is $1.55 and its 200-day simple moving average is $1.36. The firm has a market cap of $900.34 million, a price-to-earnings ratio of -134.50 and a beta of 2.24.

Olaplex (NASDAQ:OLPX) last issued its quarterly earnings results on Thursday, March 5th. The company reported $0.01 EPS for the quarter, meeting analysts’ consensus estimates of $0.01. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The firm had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. During the same quarter in the prior year, the business posted $0.01 earnings per share. Olaplex’s revenue for the quarter was up 4.4% on a year-over-year basis. As a group, equities analysts anticipate that Olaplex will post 0.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Olaplex

A number of institutional investors have recently made changes to their positions in OLPX. Portolan Capital Management LLC lifted its stake in Olaplex by 132.6% during the third quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock worth $4,762,000 after purchasing an additional 2,072,383 shares during the last quarter. Russell Investments Group Ltd. increased its stake in Olaplex by 284.7% during the fourth quarter. Russell Investments Group Ltd. now owns 1,909,836 shares of the company’s stock valued at $2,559,000 after purchasing an additional 1,413,423 shares during the last quarter. Balyasny Asset Management L.P. raised its holdings in shares of Olaplex by 1,314.1% during the second quarter. Balyasny Asset Management L.P. now owns 1,508,013 shares of the company’s stock worth $2,111,000 after purchasing an additional 1,401,369 shares during the period. Archon Capital Management LLC raised its holdings in shares of Olaplex by 40.4% during the fourth quarter. Archon Capital Management LLC now owns 4,466,876 shares of the company’s stock worth $5,986,000 after purchasing an additional 1,284,557 shares during the period. Finally, Bridgeway Capital Management LLC lifted its position in shares of Olaplex by 56.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 2,629,139 shares of the company’s stock worth $3,681,000 after buying an additional 946,265 shares during the last quarter. 87.37% of the stock is currently owned by institutional investors.

Olaplex News Summary

Here are the key news stories impacting Olaplex this week:

• Positive Sentiment: Q4 results showed revenue and EPS roughly in line with or slightly above expectations (revenue of $105.1M, EPS $0.01, revenue +4.4% YoY), which supports the view that core sales are stabilizing. OLAPLEX Reports Fourth Quarter and Fiscal Year 2025 Results
• Neutral Sentiment: Company materials — including the slide deck and earnings call transcript — are available for investors who want management’s detailed commentary on channel mix, marketing spend and strategic initiatives. These documents may clarify execution plans but have not yet convinced the market. Earnings Slide Deck / Press Release
• Neutral Sentiment: Several published call transcripts and recaps provide additional color on product innovation and transformation initiatives management emphasized; these are useful for judging whether spend will drive re-acceleration. Q4 2025 Earnings Call Transcript
• Negative Sentiment: FY2026 guidance came in muted: the revenue range ($414M–$435M) sits against Street expectations near $430M, leaving limited upside and triggering investor concern about growth re-acceleration. That weak forward guide is the main reason for the sharp share decline. Olaplex slides more than 20% on guidance concerns
• Negative Sentiment: Analyst/competitive write-ups flag that growth remains uneven across channels and that heavy marketing spend has yet to produce sustained acceleration — some analysts now view the turnaround as lagging and see downside risk to the current share price. Olaplex: The Turnaround Is Lagging
• Negative Sentiment: Market reaction has been strong; commentary and modeling from outlets note potential downside if management cannot reaccelerate revenue and margin progress given the company’s elevated marketing spend. Short-term momentum looks negative until guidance is proven conservative. OLPX Q4 deep dive: Transformation and innovation take center stage amidst muted guidance

About Olaplex

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.